Please login to the form below
women
This page shows the latest women news and features for those working in and with pharma, biotech and healthcare.
FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
While screening and prevention programmes have slashed the number of women developing cervical cancer, it remains a leading cause of cancer-related death among women globally. ... trial. He added that not all women with advanced cervical cancer will
Latest news
-
Strong five-year survival data for Kisqali in breast cancer
Novartis’ Kisqali plus letrozole offers more than a year survival benefit for postmenopausal women with HR+/HER2 advanced breast cancer. ... and pre-, peri- or postmenopausal women, as well as both first- or second-line therapy in postmenopausal women
-
Green light for Amgen’s KRAS inhibitor in the UK
Gilead’s proposed pre-reimbursement access scheme falls alarmingly short of what’s needed and will not guarantee all eligible women access to Trodelvy,” said the charity’s head, Baroness Delyth ... Morgan. “These women don’t have time to wait.
-
Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
In June, Merck completed the spin-off of women’s health company Organon, freeing up approximately $9bn for new deals and collaborations.
-
FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine
According to the US Centers for Disease Control and Prevention (CDC) and FDA, nearly all reports of these events were observed in adult women younger than 50 years old. ... Following a review of the cases, the temporary pause was lifted after regulators
-
Q&A: Claire Gillis
The Help’ by Kathryn Stockett. It was way ahead of its time, addressing the challenges of women across the class/colour divide in 1960s Jackson, Mississippi.
Strong five-year survival data for Kisqali in breast cancer
Green light for Amgen’s KRAS inhibitor in the UK
Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine
Q&A: Claire Gillis
More from news
Approximately 9 fully matching, plus 941 partially matching documents found.
Latest Intelligence
-
A growth mindset frees us to believe that anything is possible
in women’s magazines.
-
The contradictory opportunities of a virtual future in healthcare communications
How about the institutional bias against women and people of minority ethnic backgrounds in clinical trial settings?
-
Why we need to look beyond cultural competency to fix the patient diversity challenge
Disparities in health outcomes can be identified across the world, with black women in the United States over three times more likely to die as a result of pregnancy complications than
-
Why female mentorship is so powerful in pharma
But role models matter just as much, once women have entered the industry. ... Women learn from each other why it’s worth pursuing certain career paths and leadership positions.
-
The promise of precision medicine
It has a particular focus on previously understudied groups within the population, such as ethnic minorities, women and older individuals.
A growth mindset frees us to believe that anything is possible
The contradictory opportunities of a virtual future in healthcare communications
Why we need to look beyond cultural competency to fix the patient diversity challenge
Why female mentorship is so powerful in pharma
The promise of precision medicine
More from intelligence
Approximately 11 fully matching, plus 106 partially matching documents found.
Latest appointments
-
Anna Korving joins Resonant Group as non-executive director
Langland. She also created Women in Health Agency Management in 2015, an informal networking group which supports women working at director level and above in the advertising, digital, medical communications, market
-
VMLY&Rx taps Nichole Davies for global chief strategy officer role
Her experience spans a number of areas, including oncology and immunology, rare disease, respiratory, women’s health, diabetes, nutrition and hospitals.
-
GCI Health’s UK team announces three senior promotions
I am excited to continue to work in partnership with these three inspirational women as the UK business goes from strength to strength.”.
-
Ex-J&J exec Denice Torres joins bluebird bio’s board
Prior to J&J, Torres worked for 14 years at Eli Lilly in a range of commercial roles, including leading US women’s health, global neuroscience and growth hormone. ... In addition to her professional experience, Torres is the founder of The Mentoring
-
PM Society announces new co-chairs for 2020
In addition, she has previously won the IPA and Campaign magazine Women of Tomorrow 2018 Award.
Anna Korving joins Resonant Group as non-executive director
VMLY&Rx taps Nichole Davies for global chief strategy officer role
GCI Health’s UK team announces three senior promotions
Ex-J&J exec Denice Torres joins bluebird bio’s board
PM Society announces new co-chairs for 2020
More from appointments
Approximately 0 fully matching, plus 37 partially matching documents found.
Latest from PMHub
-
Three amazing women at emotive talk about what they love about medical communications
We celebrate International Women’s Day by asking three of our amazing senior women here at emotive to tell us why they value their careers in medical communications.
-
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
Lastly, Black American and Hispanic women were able to recount negative healthcare experiences that they believed were due to their gender and ethnicity.
-
Maxwellia works with 11 London for social promotion of first ever OTC contraceptive pill
1]. , finally putting more women even more in charge of their daily contraception by widening access. ... 2][3]. Matthew Hunt, MD of 11 London, said: ‘It’s about time that women can get the pill through pharmacists.
-
'Smear Word' campaign for Roche aims to break taboos and save lives
Many young women do not turn up for appointments, which puts them at risk of early signs of cervical cancer being missed. ... women and people with a cervix to own their health and have the confidence to go for their smear tests.”.
-
How do ethnic minority groups in the U.S. view clinical trials?
This was particularly among Black American and Hispanic women. Numerous women expressed concern that the care they were receiving was suboptimal in comparison to their white counterparts. ... Medical professionals are not as keen to listen to women of
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
Maxwellia works with 11 London for social promotion of first ever OTC contraceptive pill
How do ethnic minority groups in the U.S. view clinical trials?
More from PMHub
Approximately 14 fully matching, plus 104 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- US demand for COVID-19 antibody treatments rising fast
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- EU “still interested” in Valneva COVID vaccine despite UK snub
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
- AstraZeneca invests in RNA tech platform
- Market shaping demands behaviour change
- Healthcare Access and Payment Reform in the US
- Advancing Drug Discovery with Structured and Intelligent Data
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Advancing Drug Discovery with Structured and Intelligent Data
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Ashfield Health announces three new senior hires
- Future of MHRA uncertain amid Brexit-fuelled shake up
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
